OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.
OMNIQ Corp. Reports Strong Sales of $15.8 Million for Third Quarter of 2020, up 21% Year over Year
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
NanoVibronix Announces Closing of $3.2 Million Private Placement to Existing Shareholders.
Adding to Watch List @ $2.95*...
Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)
AIRPORT CITY, Israel, June 27, 2019 /PRNewswire/ -- My Size, Inc. (the "Company" or "My Size") (MYSZ) (MYSZ), the developer and creator of smartphone measurement solutions,...
Newsletter: Institutional Analyst. And Yes, We Have Another Double.
1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....
A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.
With Toronto Grabbing Some of the Best Israeli Tech Listings Away From NASDAQ, We Saw This Coming.
From...
OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...
OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...
Two of Our $5.00 Watch List Stocks Double, in Like Just Five Months!
Added to the Watch List in November, OMNIQ (OMQS) and Galaxy Digital (GLXY) Shine like a Pretty Penny, with OMNIQ Doubling...
Internet Stock Review Adds MySize (MYSZ) $0.45 to Watch List.
Short Term Turbulence Creates Potential Entry Point at $0.45.
Investors appeared to react...
Latest article
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
